Non Animal Testing Database

New therapeutic strategy for celiac disease tested with human intestinal cells in vitro

University of Pavia, Pavia, Italy
Celiac disease (CD) is a chronic systemic autoimmune disease by the ingestion of gluten, a storage protein present in many cereals, which affects the small intestine of individuals with a genetic predisposition. The pathological immune response is caused by a fraction of gluten called gliadin which shows toxic properties. In this study, the researchers aimed at investigating the effect of trehalose, a compound known for increasing autophagy, on counteracting gliadin cytotoxicity in the context of CD. The capability of trehalose to induce autophagy in a CD was assessed in an in vitro model based on human intestinal cells. Trehalose promoted autophagy in the intestinal cells treated with digested gliadin as well as improved cell viability. Moreover, trehalose reduced the intracellular levels of these toxic peptides. In conclusion, these results showed the beneficial effects of trehalose in a CD in vitro model, they also indicate that underlining autophagy is a molecular pathway to counteract gliadin cytotoxicity.
Trehalose modulates autophagy process to counteract gliadin cytotoxicity in an in vitro celiac disease model
Federico Manai
Added on: 10-29-2021
Back to Top
English German

Warning: Internet Explorer

The IE from MS no longer understands current scripting languages, the latest main version (version 11) is from 2013 and has not been further developed since 2015.

Our recommendation: Use only the latest versions of modern browsers, for example Google Chrome, Mozilla Firefox or Microsofrt Edge, because only this guarantees you sufficient protection against infections and the correct display of websites!